References
- 1. Zareba W, Zareba KM. Cardiac Magnetic Resonance in Sudden Cardiac Arrest Survivors. Circ Cardiovasc Imaging. 2017;10:e007290. doi: 10.1161/CIRCIMAGING.117.007290.29237610
- 2. White JA, Fine NM, Gula L, et al. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ Cardiovasc Imaging. 2012;5:12-20. doi: 10.1161/CIRCIMAGING.111.966085.22038987
- 3. Eitel I, Desch S, de Waha S, et al. Long-term prognostic value of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. Heart. 2011;97:2038-2045. doi: 10.1136/heartjnl-2011-300098.21990384
- 4. Wong TC, Piehler KM, Zareba KM, Lin K, et al. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiovascular Magnetic Resonance Is Associated With Subsequent Hospitalization for Heart Failure. JAHA. 2013;2:e000416. doi: 10.1161/JAHA.113.000416.388678124249712
- 5. Messroghli DR, Moon JC, Ferreira VM, et al. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;19:75. doi: 10.1186/s12968-017-0389-8.563304128992817
- 6. Rodrigues P, Joshi A, Williams H, et al. Diagnosis and Prognosis in Sudden Cardiac Arrest Survivors Without Coronary Artery Disease: Utility of a Clinical Approach Using Cardiac Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2017;10:e006709. doi: 10.1161/CIRCIMAGING.117.006709.29237609
- 7. Emrich T, Halfmann M, Schoepf UJ, Kreitner KF. CMR for myocardial characterization in ischemic heart disease: state-of-the-art and future developments. Eur Radiol Exp. 2021;5:14. doi: 10.1186/s41747-021-00208-2.799098033763757
- 8. Reindl M, Eitel I, Reinstadler SJ. Role of Cardiac Magnetic Resonance to Improve Risk Prediction following Acute ST-elevation Myocardial Infarction. J Clin Med. 2020;9:1041. doi: 10.3390/jcm9041041.723109532272692
- 9. Schulz-Menger J, Bluemke DA, Bremerich J, et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance – 2020 update: Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn Reson. 2020;22:19. doi: 10.1186/s12968-020-00610-6.706676332160925
- 10. Moosa S, Ntusi N. Role of cardiovascular magnetic resonance in the evaluation of cardiomyopathy. South African Journal of Radiology. 2016;20:1-10. doi: 10.4102/sajr.v20i2.1055.
- 11. Eitel I, de Waha S, Wöhrle J, et al. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014;64:1217-1226. doi: 10.1016/j.jacc.2014.06.1194.25236513
- 12. Reindl M, Reinstadler SJ, Tiller C, Feistritzer HJ, Kofler M, Brix A, Mayr A, Klug G, Metzler B. Prognosis-based definition of left ventricular remodeling after ST-elevation myocardial infarction. Eur Radiol. 2019;29:2330-2339. doi: 10.1007/s00330-018-5875-3.644391630547201
- 13. Frantz S, Hundertmark MJ, Schulz-Menger J, Bengel FM, Bauersachs J. Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies. Eur Heart J. 2022;43:2549-2561. doi: 10.1093/eurheartj/ehac223.933658635511857
- 14. Benedek I, Bucur O, Benedek T. Intracoronary Infusion of Mononuclear Bone Marrow-Derived Stem Cells is Associated with a Lower Plaque Burden After Four Years. J Atheroscler Thromb. 2014;21:217-229. doi: 10.5551/jat.19745.24126180
- 15. Gyöngyösi M, Hemetsberger R, Posa A, et al. Hypoxiainducible factor 1-alpha release after intracoronary versus intramyocardial stem cell therapy in myocardial infarction. J Cardiovasc Transl Res. 2010;3:114-121. doi: 10.1007/s12265-009-9154-1.20560024